Targeting the innate immune response with improved vaccine adjuvants. - Wikidata - wikimedia - TriplyDB

Targeting the innate immune response with improved vaccine adjuvants.

Targeting the innate immune response with improved vaccine adjuvants.

http://www.wikidata.org/entity/Q36090194

about

Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses AntigenDB: an immunoinformatics database of pathogen antigens Adjuvants: Classification, Modus Operandi, and Licensing Systems biology applied to vaccine and immunotherapy development Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins Enhanced protective immunity of the chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever in pigs by a Salmonella bacterial ghost adjuvant Current Status of Veterinary Vaccines Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating.Molecular and cellular signatures of human vaccine adjuvants.Pandemic influenza vaccines - the challenges.Virus-like particles as universal influenza vaccines Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay Immunogenomics and systems biology of vaccines.High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors.Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles Identification of probable early-onset biomarkers for tuberculosis disease progression.Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery.In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines Bacterial superglue enables easy development of efficient virus-like particle based vaccines.Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses.Immunotherapy for lung cancers.IL-28B is a key regulator of B- and T-cell vaccine responses against influenza Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses.Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells Small-molecule inhibitors of the TLR3/dsRNA complex Fundamentals of vaccine immunology.Scrutinizing MHC-I binding peptides and their limits of variation Therapeutic cancer vaccines: are we there yet?Vaccines: all things considered.

P2860

Q24624348-E4D2B0B5-9B86-4A8E-901F-D3520A17F55D Q24644600-EE69EB0D-4F71-492D-96C0-4979BD3BD1F4 Q26747586-DB157B8C-E183-4213-9928-D00B8F378F8D Q26830374-061473EB-E13F-4DAD-9724-4C91BBFE94FF Q27310086-6980B29C-8F98-4700-A761-4D18608FEDE4 Q27311087-AA665637-D3A5-487F-BCC3-0DD2E5793915 Q27469061-10F2721F-EF6A-4407-8F5D-98ECA3BB8A68 Q27480923-E166E1B3-A9D6-4D49-8950-16ADF1F9EFCC Q27488746-98EC08EB-8FC7-447E-B7F0-28E8849C4BA8 Q28068082-1654854E-4520-4312-9E30-9536B9B39AC2 Q28729899-609939E7-6F3D-4C7B-9FBB-4B7485015435 Q30229190-DC5FF096-E808-4B1C-8902-FD04324A3C03 Q30241084-CEEA4235-DBC8-431F-AFFA-93EE03837D3A Q30370898-9D45BD6A-A274-4EDD-90E9-BD92E987AB6B Q30408091-DAD053F6-C8BD-4972-B2D5-BB72CA15ACDC Q30421558-19467274-8C62-4746-B519-DFD363602545 Q33256133-EEF0CF13-CE0A-40C6-86BD-36E4CF24B89D Q33350387-D03CCA34-D2E8-4FFB-B253-E5B85D2262AB Q33552169-F1075EBD-80C4-406B-A7D2-19551A65025F Q33591916-C71B6DF2-BBBC-4DFD-B781-4D269CE96225 Q33668447-DE78683C-82E5-4ED0-B76B-BF6EB3900228 Q33802696-31A2DD6F-5C87-4FBB-B2A9-21586ACC92A6 Q33825688-E12AD874-FFCF-4B57-9637-4DCAB93E6CDF Q34038097-DEE1F8DE-B2BE-41ED-8CE0-30F4DCA3C2D9 Q34057901-F72127DE-E5B9-47A3-8270-BCD8C026C62B Q34197336-C33E89F3-BC18-45A5-974B-53E1A526DE8E Q34356322-3F3102CB-CEF6-4A30-B9EE-BA460A8D993E Q34523734-3C4AFBE0-40F5-4F78-97EF-DA5279BFFE06 Q34557185-C369A3CE-E1C7-4669-AE29-8C51CEE48DEF Q34557611-24EB7986-C0F7-4357-91F4-29C36B5A7C40 Q34682206-0B30EE36-B325-4BF9-8857-6D5C34457CA8 Q34717036-F35AED4B-2992-46A9-9201-9FCC7759BC7D Q34718609-29B7364D-030F-419D-8660-C19F39CE7772 Q34721219-6FE9A2A7-4EDF-4C66-9763-696470DC19F5 Q34735203-638BFB3B-C0E6-4EFD-AB97-217AE0D7A9DF Q34746236-8F1BE910-F399-46FB-91AA-A59DAE790C9C Q34746587-2A6F15F9-2AF1-476A-BDCF-062C84D1ECEA Q34765261-6BE11D06-B5F4-4430-ADD9-DA6917B85D93 Q34786691-02477160-0226-4666-9205-81E863D4A34E Q34975057-0094522C-9BF1-4543-BC62-75A010ADC05B

P2860

Targeting the innate immune response with improved vaccine adjuvants.

http://www.wikidata.org/entity/Q36090194

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Targeting the innate immune response with improved vaccine adjuvants.

@ast

Targeting the innate immune response with improved vaccine adjuvants.

@en

type

label

Targeting the innate immune response with improved vaccine adjuvants.

@ast

Targeting the innate immune response with improved vaccine adjuvants.

@en

prefLabel

Targeting the innate immune response with improved vaccine adjuvants.

@ast

Targeting the innate immune response with improved vaccine adjuvants.

@en

P1433

Q36090194-AE124752-97B1-424F-8DD1-993A8C6CFB1E

P1476

Q36090194-78A8A341-6AA7-4803-8543-26B63F19C199

P2093

Q36090194-D39C5196-1073-4352-8ED4-E55ADC2010D4

Q36090194-F2A124A9-29D2-4DFE-AE6B-0A371796E636

Q36090194-F7B69747-ED68-43FD-9CFD-A1C3DED82443

P2860

Q36090194-17DE155D-B231-415D-B5A6-BC8C5C07BC0C

Q36090194-1B32F4AB-2ECE-4D7F-8D20-B6E65E9E15E8

Q36090194-1CBE472F-2F06-48C8-B175-A339DEAFEC44

Q36090194-2645E0EC-36CD-4243-B79F-77303527D9BA

Q36090194-2D254395-A1C1-4BB2-9A1F-3C5E0807AE76

Q36090194-2DDC03FA-8F9C-405A-8D18-FBF4F6E18925

Q36090194-3463B2F3-2931-4CBB-AE1F-CC583CCB0BDB

Q36090194-44192828-1AB1-4C90-A5DA-9F3710775518

Q36090194-5D7A4D6D-2E35-4CFD-AC97-5BE8D06B2FD1

Q36090194-851D544A-9DC0-4F64-8E01-8216F2B1688E

P2888

Q36090194-22C0EAFD-C500-40F7-A591-ABEC66796230

P304

Q36090194-0A726A4C-431A-4BA6-9F62-F3601FDB2EF5

P31

Q36090194-744E88CE-E657-47AF-B832-2022C847FAA5

P356

Q36090194-9F1EA41E-661C-46D3-9B20-D73CFB024853

P407

Q36090194-377A629C-332C-489A-9C50-5029274B1C2C

P433

Q36090194-40B5EE8D-F291-4363-8292-06FBE534B64F

P478

Q36090194-694C6CBE-2216-45E9-8CE9-E5933657A63D

P577

Q36090194-9726C81D-02FA-4A6A-8E98-272524FBE4F0

P5875

Q36090194-39E8EE65-B219-43DC-9E6E-F8F90550A3A5

P6179

Q36090194-D9C5517D-6FD5-447F-96AE-27B15C71520E

P698

Q36090194-9481EA69-10D6-4857-8CFE-F7C0C9C928F0

P356

P1433

Nature Medicine

P1476

Targeting the innate immune response with improved vaccine adjuvants.

@en

P2093

Achal Pashine

http://www.w3.org/2001/XMLSchema#string

Jeffrey B Ulmer

http://www.w3.org/2001/XMLSchema#string

Nicholas M Valiante

http://www.w3.org/2001/XMLSchema#string

P2860

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

Toll-like receptor signalling

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Approaching the asymptote? Evolution and revolution in immunology

Toll-like receptor control of the adaptive immune responses

Immunobiology of dendritic cells

Innate immunity: the virtues of a nonclonal system of recognition

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A.

P2888

P304

S63-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1210

http://www.w3.org/2001/XMLSchema#string

P407

P433

4 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7924908

http://www.w3.org/2001/XMLSchema#string

P6179

1019008331

http://www.w3.org/2001/XMLSchema#string

P698

15812492

http://www.w3.org/2001/XMLSchema#string